Comparative Study About the Effect of Aquatic Therapy vs Land-based Therapy in Women With Fibromyalgia

March 27, 2025 updated by: Sabela Rivas Neira, PhD, Universidade da Coruña

Comparative Study About the Effect of a Physical Therapy Protocol in Warm Water vs Land-based Therapy in Women With Fibromyalgia Syndrome

Fibromyalgia is a disease whose incidence rate is increasing and causing a severe disability to those who suffer it. Currently, other treatment resources are being implemented, such as aquatic therapy. This therapy seems to provide positive results in different dimensions of fibromyalgia.

The main objective of the study is to determine the effectiveness of a physical therapy program in warm water vs. land-based therapy in women with fibromyalgia for pain reduction and improvement balance at the end of treatment and a month and a half later (follow-up).

The type of study is a randomized controlled opened trial. The sample is composed of 34 women with age between 35 and 64 years and fibromyalgia diagnosis who will be divided into 2 groups: Aquatic Therapy Group (n=17) and Land-Based Therapy Group (n=17). This study will have two primary outcomes: Pain and balance. The intensity of pain will be assessed using the visual analog scale (VAS) and the pain threshold for each one of the 18 tender points will be assessed using a electronic algometer. Static balance will be evaluated with the Romberg's test and the dynamic balance with the Timed Up & Go test (TUG) and Berg Balance Scale. Both type of balance will be recorded in slow motion and then, will be analysed with a motion software. Secondary outcomes are: The impact of fibromyalgia on patient's lives, that will be measured with the "Revised Fibromyalgia Impact Questionnaire" (FIQR); the sleep quality, that will be assessed with the "Pittsburgh Sleep Quality Index" (PSQI); the fatigue, that will be evaluated witn the "Multidimensional Fatigue Inventory" (MFI); the physical capacity, that will be measured with the "six minute walk test" (SMWT) and confidence in balance that will be assessed with the "Activities-specific Balance Confidence" scale (ABC).

Each intervention will last one hour and will be made 3 times a week for three months . It will consist of 4 sections: Warming, exercises for static and dynamic balance training, stretching and relaxation. Statistical analysis will be made using the Statistical Package for the Social Sciences software, version 21.0 for Windows. p ≤ 0.05 will be the significance level set for all analysis.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • A Coruña, Spain, 15006
        • Asociación Coruñesa de Fibromialgia, Síndrome de Fatiga Crónica y Sensibilidad Química Múltiple (ACOFIFA)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 64 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Female.
  • Age range between 35 and 64 years.
  • Diagnosis of fibromyalgia according to the criteria of the American College of Rheumatology (ACR) in 1990 and 2010.
  • Mark ≥ 4 on the Visual Analogue Scale (VAS).
  • Mark ≥ 5 on the Visual Analogue Scale for balance included in The Revised Fibromyalgia Impact Questionnaire (FIQR).

Exclusion Criteria:

  • History of severe trauma.
  • Neurological diseases (stroke, Parkinson's disease, dementia).
  • Frequent migraines.
  • Inflammatory rheumatic diseases.
  • People who have been treated in the past six months by traumatic injuries.
  • Being pregnant.
  • Visual or hearing deficits uncorrected.
  • Infectious diseases.
  • Severe cardiovascular disease.
  • People who do exercise regularly more than 20 minutes, more than 3 times a week in the past 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aquatic therapy
Aquatic therapy is the experimental group. This therapy will take place in a warm pool which is located in Rialta's Sports Complex. Aquatic therapy session will be conducted by the main researcher with the help of an assistant. Because the number of patients (n=17), they will be subdivided into two subgroups of 8 and 9 people respectively in order to ensure the safety and care of patients. The intervention will last for one hour: Warming (15 minutes); exercises to train the static and dynamic balance (25 minutes); stretching (10 minutes); relaxation (10 minutes). Over 12 weeks of treatment, difficulty in performing exercises to train balance will increase progressively.
Pool material is contributed by Maria José Jove Foundation. The exercises that will be made during treatment, are designed and developed to improve "core" muscles and, in this way, improve postural balance.
Other: Land-based therapy
The description is the same as aquatic therapy. The difference is land-based therapy sessions will be made at Faculty of Physiotherapy at University of "A Coruña".

The material is contributed by Faculty of Physiotherapy at University of "A Coruña".

The exercises that will be made during treatment, are designed and developed to improve "core" muscles and, in this way, improve postural balance.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Pain at 3 months of therapy and one month and a half after treatment.
Time Frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
Pain will be assessed using the visual analog scale (VAS).
It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
Change from baseline Static Balance at 3 months of therapy and one month and a half after treatment.
Time Frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
It will be evaluated with the Romberg's test, whose execution will be filmed in slow motion and then, these videos will be analysed with a motion software.
It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
Change from baseline Dynamic Balance at 3 months of therapy and one month and a half after treatment.
Time Frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
It will be assessed using the Timed Up & Go test (TUG), whose execution will be filmed in slow motion and then, these videos will be analysed with a motion software.
It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Quality of Life at 3 months of therapy and one month and a half after treatment.
Time Frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
It will be measured with the "Revised Fibromyalgia Impact Questionnaire" (FIQR).
It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
Change from baseline Sleep Quality at 3 months of therapy and one month and a half after treatment.
Time Frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
It will be assessed with the "Pittsburgh Sleep Quality Index" (PSQI).
It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
Change from baseline Fatigue at 3 months of therapy and one month and a half after treatment.
Time Frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
It will be evaluated with the "Multidimensional Fatigue Inventory" (MFI).
It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
Change from baseline Physical Capacity at 3 months of therapy and one month and a half after treatment.
Time Frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
It will be measured with the "six minute walk test" (SMWT).
It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
Change from baseline Confidence in Balance at 3 months of therapy and one month and a half after treatment.
Time Frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
It will be assessed with the "Activities-specific Balance Confidence" scale (ABC).
It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
Change from baseline Pain Threshold for each one of the 18 tender points established at 3 months of therapy and one month and a half after treatment.
Time Frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
It will be assessed using an electronic algometer.
It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
Change from baseline Functional Independence to perform activities of daily living at 3 months of therapy and one month and a half after treatment.
Time Frame: It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).
It will be assessed using the Berg Balance Scale.
It will be measured at baseline, at 3 months of therapy and one month and a half after treatment (follow-up).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sabela Rivas Neira, Physiotherapy, Facultade de Fisioterapia da Universidade da Coruña
  • Study Director: Jamile Vivas Costa, Physiotherapy, Facultade de Fisioterapia da Universidade da Coruña

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2016

Primary Completion (Actual)

August 1, 2016

Study Completion (Actual)

December 1, 2024

Study Registration Dates

First Submitted

February 18, 2016

First Submitted That Met QC Criteria

February 24, 2016

First Posted (Estimated)

March 1, 2016

Study Record Updates

Last Update Posted (Actual)

April 2, 2025

Last Update Submitted That Met QC Criteria

March 27, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fibromyalgia

Clinical Trials on Aquatic therapy

Subscribe